These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17235303)

  • 1. Long-term suppression of experimental arthritis following intramuscular administration of a pseudotyped AAV2/1-TNFR:Fc Vector.
    Sandalon Z; Bruckheimer EM; Lustig KH; Burstein H
    Mol Ther; 2007 Feb; 15(2):264-9. PubMed ID: 17235303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product.
    Chan JM; Villarreal G; Jin WW; Stepan T; Burstein H; Wahl SM
    Mol Ther; 2002 Dec; 6(6):727-36. PubMed ID: 12498769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors.
    Sandalon Z; Bruckheimer EM; Lustig KH; Rogers LC; Peluso RW; Burstein H
    J Virol; 2004 Nov; 78(22):12355-65. PubMed ID: 15507622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression.
    Cirelli JA; Park CH; MacKool K; Taba M; Lustig KH; Burstein H; Giannobile WV
    Gene Ther; 2009 Mar; 16(3):426-36. PubMed ID: 19078994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene.
    Zhou X; Shen L; Liu L; Wang C; Qi W; Zhao A; Wu X; Li B
    Hum Vaccin Immunother; 2016 Mar; 12(3):732-9. PubMed ID: 26837862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.
    Mease PJ; Wei N; Fudman EJ; Kivitz AJ; Schechtman J; Trapp RG; Hobbs KF; Greenwald M; Hou A; Bookbinder SA; Graham GE; Wiesenhutter CW; Willis L; Ruderman EM; Forstot JZ; Maricic MJ; Dao KH; Pritchard CH; Fiske DN; Burch FX; Prupas HM; Anklesaria P; Heald AE
    J Rheumatol; 2010 Apr; 37(4):692-703. PubMed ID: 20032102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
    Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE
    Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.
    Adriaansen J; Khoury M; de Cortie CJ; Fallaux FJ; Bigey P; Scherman D; Gould DJ; Chernajovsky Y; Apparailly F; Jorgensen C; Vervoordeldonk MJ; Tak PP
    Ann Rheum Dis; 2007 Sep; 66(9):1143-50. PubMed ID: 17363402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with TNFR-Fc and CTLA4-FasL using the recombinant adeno-associated virus potently suppresses adjuvant-induced arthritis in rats.
    Wang F; Yu J; Wang Y; Jiang Y; Guo N; Zhang W
    Appl Microbiol Biotechnol; 2015 Aug; 99(15):6327-37. PubMed ID: 25707864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy.
    Machen J; Bertera S; Chang Y; Bottino R; Balamurugan AN; Robbins PD; Trucco M; Giannoukakis N
    Gene Ther; 2004 Oct; 11(20):1506-14. PubMed ID: 15229635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.
    Moreland LW; Baumgartner SW; Schiff MH; Tindall EA; Fleischmann RM; Weaver AL; Ettlinger RE; Cohen S; Koopman WJ; Mohler K; Widmer MB; Blosch CM
    N Engl J Med; 1997 Jul; 337(3):141-7. PubMed ID: 9219699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of human tumor necrosis factor receptor-Fc fusion protein and characterization of its biological activity].
    Du Z; Wang F; Zhu J; Yu J; Wang Y; Zhu X; Zhang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Mar; 30(3):225-8. PubMed ID: 24606734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful gene therapy via intraarticular injection of adenovirus vector containing CTLA4IgG in a murine model of type II collagen-induced arthritis.
    Ijima K; Murakami M; Okamoto H; Inobe M; Chikuma S; Saito I; Kanegae Y; Kawaguchi Y; Kitabatake A; Uede T
    Hum Gene Ther; 2001 Jun; 12(9):1063-77. PubMed ID: 11399228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cloning and expression of human TNFR (P55)-IgG Fc fusion protein in eukaryotic cells].
    An N; Xu C; Zhang Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):116-7. PubMed ID: 11436637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.
    Aalbers CJ; Bevaart L; Loiler S; de Cortie K; Wright JF; Mingozzi F; Tak PP; Vervoordeldonk MJ
    PLoS One; 2015; 10(6):e0130612. PubMed ID: 26107769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts.
    McTiernan CF; Mathier MA; Zhu X; Xiao X; Klein E; Swan CH; Mehdi H; Gibson G; Trichel AM; Glorioso JC; Feldman AM; McCurry KR; London B
    Gene Ther; 2007 Dec; 14(23):1613-22. PubMed ID: 17851548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis.
    Zhang HG; Xie J; Yang P; Wang Y; Xu L; Liu D; Hsu HC; Zhou T; Edwards CK; Mountz JD
    Hum Gene Ther; 2000 Nov; 11(17):2431-42. PubMed ID: 11096446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Culture Temperature on the Aggregation of Recombinant TNFR-Fc is Regulated by the PERK-eIF2a Pathway in CHO Cells.
    Wang K; Zhang T; Chen J; Liu C; Tang J; Xie Q
    Protein Pept Lett; 2018; 25(6):570-579. PubMed ID: 29848262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis.
    Oligino T; Ghivizzani S; Wolfe D; Lechman E; Krisky D; Mi Z; Evans C; Robbins P; Glorioso J
    Gene Ther; 1999 Oct; 6(10):1713-20. PubMed ID: 10516720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.